Microenvironment-adaptive drug delivery systems for ulcerative colitis: from pathological constraints to rational design.
A pathology-driven microenvironment-adaptive framework is proposed and the limitations of current delivery strategies are critically evaluated, followed by a discussion of how molecular building blocks and delivery platforms can be engineered to realize microenvironment-adaptive therapeutic strategies.